SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Profit Before Tax | ₹-387 Cr | ₹-223 Cr |
Adjustment | ₹-11 Cr | ₹6.99 Cr |
Changes In working Capital | ₹-27 Cr | ₹141 Cr |
Cash Flow after changes in Working Capital | ₹-425 Cr | ₹-74 Cr |
Cash Flow from Operating Activities | ₹-429 Cr | ₹-69 Cr |
Cash Flow from Investing Activities | ₹392 Cr | ₹-548 Cr |
Cash Flow from Financing Activities | ₹42 Cr | ₹617 Cr |
Net Cash Inflow / Outflow | ₹4.74 Cr | ₹-0.64 Cr |
Opening Cash & Cash Equivalents | ₹0.58 Cr | ₹1.22 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | ₹0.00 Cr | - |
Closing Cash & Cash Equivalent | ₹5.33 Cr | ₹0.58 Cr |
Compare Cashflow Statement of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,885.3 Cr | -9.3% | -9.3% | -32.9% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹25,252.2 Cr | -4% | -1.9% | -8.9% | Stock Analytics | |
SAGILITY INDIA | ₹18,875.1 Cr | 3.4% | -8.8% | NA | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹8,285.7 Cr | 0.6% | -1.6% | -19.8% | Stock Analytics | |
JUST DIAL | ₹7,397.2 Cr | -2.9% | -5.3% | -15.9% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,611.3 Cr | 0.4% | -1.3% | 36.8% | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -9.3% |
-9.3% |
-32.9% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses